Hydroxyapatite Orbital Implant in Pediatric Patients with Retinoblastoma
Journal of the Korean Ophthalmological Society
;
: 1225-1232, 2006.
Article
in Korean
| WPRIM
| ID: wpr-103821
ABSTRACT
PURPOSE:
To evaluate the clinical results of implantation of hydroxyapatite orbital implant in patients with retinoblastoma.METHODS:
The medical records of 31 children who had undergone hydroxyapatite implantation after enucleation or secondary hydroxyapatite implantation, for retinoblastoma from April 1994 to January 2006 were reviewed retrospectively.RESULTS:
The mean age at the time of operation was 64.1 months (range, 1 to 247 months). The mean follow-up period was 35.3 months (range, 3 to 139 months). The diameter of the orbital implants most used was 20 mm (35.4%, range, 16~21 mm). Tutoplast(R), Vicryl mesh(R), and Neuropatch(R) were used as the wrapping materials for hydroxyapatite orbital implant. Of 31 patients (31 eyes), 8 eyes were found to have complications 6 eyes showed lower lid sagging (19.4%), 1 eye granulation tissue overgrowth (3.2%) and 1 eye conjunctival sac contracture (3.2%). Exposure of the hydroxyapatite orbital implant occurred in 1 eye (3.2%).CONCLUSIONS:
Hydroxyapatite implantation in children with retinoblastoma showed good surgical results and minimal complications.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Orbit
/
Polyglactin 910
/
Retinoblastoma
/
Medical Records
/
Retrospective Studies
/
Follow-Up Studies
/
Durapatite
/
Contracture
/
Orbital Implants
/
Granulation Tissue
Type of study:
Observational study
/
Prognostic study
Limits:
Child
/
Humans
Language:
Korean
Journal:
Journal of the Korean Ophthalmological Society
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS